The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 ...

Despegar.com, Corp. (NYSE: DESP) ("Despegar" or the "Company"), Latin America’s leading travel technology company, today announced unaudited financial results for the three-months ended September 30, ...

Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, has reported results for its fiscal second ...